
The Wall Street Journal @WSJ
Breaking: Novo Nordisk, a large insulin maker, plans to cut the prices of its widely used products up to 75% to make them more affordable for patients. This follows a similar move by Eli Lilly. https://t.co/odQofrGKew — PolitiTweet.org